APO Research, Inc.

APO RESEARCH · REPORT

Antiemetics

Selected research

Industry Growth & Trends

Global Antiemetics Industry Growth and Trends Forecast to 2032

Market perspective

The global Antiemetics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antiemetics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antiemetics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiemetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antiemetics include Johnson & Johnson, Merck, Eli Lilly, Pfizer, GlaxoSmithKline, Baxter, Sanofi Aventis, Bristol Myers Squibb and Astellas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antiemetics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antiemetics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antiemetics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antiemetics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antiemetics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antiemetics Market by Company

Johnson & Johnson

Merck

Eli Lilly

Pfizer

GlaxoSmithKline

Baxter

Sanofi Aventis

Bristol Myers Squibb

Astellas

Antiemetics Segment by Type

Steroids

Antihistamines (H1 histamine receptor antagonists)

Anticholinergics

Dopamine antagonists

Cannabinoids

Benzodiazepines

NK1 receptor antagonist

5-HT3 receptor antagonists

Others

Antiemetics Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Others

Antiemetics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiemetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiemetics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiemetics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antiemetics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antiemetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Steroids Table 2. Major Company of Antihistamines (H1 histamine receptor antagonists) Table 3. Major Company of Anticholinergics Table 4. Major Company of Dopamine antagonists Table 5. Major Company of Cannabinoids Table 6. Major Company of Benzodiazepines Table 7. Major Company of NK1 receptor antagonist Table 8. Major Company of 5-HT3 receptor antagonists Table 9. Major Company of Others Table 10. Global Antiemetics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 11. Global Antiemetics Sales by Type (2021-2026) & (K Units) Table 12. Global Antiemetics Sales Market Share in Volume by Type (2021-2026) Table 13. Global Antiemetics Sales by Type (2021-2026) & (US$ Million) Table 14. Global Antiemetics Sales Market Share in Value by Type (2021-2026) Table 15. Global Antiemetics Price by Type (2021-2026) & (US$/Unit) Table 16. Global Antiemetics Sales by Type (2027-2032) & (K Units) Table 17. Global Antiemetics Sales Market Share in Volume by Type (2027-2032) Table 18. Global Antiemetics Sales by Type (2027-2032) & (US$ Million) Table 19. Global Antiemetics Sales Market Share in Value by Type (2027-2032) Table 20. Global Antiemetics Price by Type (2027-2032) & (US$/Unit) Table 21. North America Antiemetics Sales by Type (2021-2026) & (K Units) Table 22. North America Antiemetics Sales by Type (2021-2026) & (US$ Million) Table 23. Europe Antiemetics Sales by Type (2021-2026) & (K Units) Table 24. Europe Antiemetics Sales by Type (2021-2026) & (US$ Million) Table 25. Asia-Pacific Antiemetics Sales by Type (2021-2026) & (K Units) Table 26. Asia-Pacific Antiemetics Sales by Type (2021-2026) & (US$ Million) Table 27. Latin America Antiemetics Sales by Type (2021-2026) & (K Units) Table 28. Latin America Antiemetics Sales by Type (2021-2026) & (US$ Million) Table 29. Middle East and Africa Antiemetics Sales by Type (2021-2026) & (K Units) Table 30. Middle East and Africa Antiemetics Sales by Type (2021-2026) & (US$ Million) Table 31. Antiemetics Industry Trends Table 32. Antiemetics Industry Drivers Table 33. Antiemetics Industry Opportunities and Challenges Table 34. Antiemetics Industry Restraints Table 35. Global Antiemetics Sales Revenue by Company (US$ Million) & (2021-2026) Table 36. Global Antiemetics Revenue Market Share by Company (2021-2026) Table 37. Global Antiemetics Sales by Company (2021-2026) & (K Units) Table 38. Global Antiemetics Sales Share by Company (2021-2026) Table 39. Global Antiemetics Market Price by Company (2021-2026) & (US$/Unit) Table 40. Global Antiemetics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 41. Global Antiemetics Major Company Production Sites and Headquarters Table 42. Global Antiemetics Company, Product Type & Application Table 43. Global Antiemetics Company Establishment Date Table 44. Global Company Market Concentration Ratio (CR5 and HHI) Table 45. Global Antiemetics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 46. Global Antiemetics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 47. Global Antiemetics Sales by Region (2021-2026) & (K Units) Table 48. Global Antiemetics Sales Market Share in Volume by Region (2021-2026) Table 49. Global Antiemetics Sales by Region (2021-2026) & (US$ Million) Table 50. Global Antiemetics Sales Market Share in Value by Region (2021-2026) Table 51. Global Antiemetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 52. Global Antiemetics Sales by Region (2027-2032) & (K Units) Table 53. Global Antiemetics Sales Market Share in Volume by Region (2027-2032) Table 54. Global Antiemetics Sales by Region (2027-2032) & (US$ Million) Table 55. Global Antiemetics Sales Market Share in Value by Region (2027-2032) Table 56. Global Antiemetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 57. Global Antiemetics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 58. Global Antiemetics Sales by Application (2021-2026) & (K Units) Table 59. Global Antiemetics Sales Market Share in Volume by Application (2021-2026) Table 60. Global Antiemetics Sales by Application (2021-2026) & (US$ Million) Table 61. Global Antiemetics Sales Market Share in Value by Application (2021-2026) Table 62. Global Antiemetics Price by Application (2021-2026) & (US$/Unit) Table 63. Global Antiemetics Sales by Application (2027-2032) & (K Units) Table 64. Global Antiemetics Sales Market Share in Volume by Application (2027-2032) Table 65. Global Antiemetics Sales by Application (2027-2032) & (US$ Million) Table 66. Global Antiemetics Sales Market Share in Value by Application (2027-2032) Table 67. Global Antiemetics Price by Application (2027-2032) & (US$/Unit) Table 68. North America Antiemetics Sales by Application (2021-2026) & (K Units) Table 69. North America Antiemetics Sales by Application (2021-2026) & (US$ Million) Table 70. Europe Antiemetics Sales by Application (2021-2026) & (K Units) Table 71. Europe Antiemetics Sales by Application (2021-2026) & (US$ Million) Table 72. Asia-Pacific Antiemetics Sales by Application (2021-2026) & (K Units) Table 73. Asia-Pacific Antiemetics Sales by Application (2021-2026) & (US$ Million) Table 74. Latin America Antiemetics Sales by Application (2021-2026) & (K Units) Table 75. Latin America Antiemetics Sales by Application (2021-2026) & (US$ Million) Table 76. Middle East and Africa Antiemetics Sales by Application (2021-2026) & (K Units) Table 77. Middle East and Africa Antiemetics Sales by Application (2021-2026) & (US$ Million) Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson Antiemetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Johnson & Johnson Antiemetics Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Antiemetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Merck Antiemetics Product Portfolio Table 87. Merck Recent Development Table 88. Eli Lilly Company Information Table 89. Eli Lilly Business Overview Table 90. Eli Lilly Antiemetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Eli Lilly Antiemetics Product Portfolio Table 92. Eli Lilly Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Antiemetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Pfizer Antiemetics Product Portfolio Table 97. Pfizer Recent Development Table 98. GlaxoSmithKline Company Information Table 99. GlaxoSmithKline Business Overview Table 100. GlaxoSmithKline Antiemetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline Antiemetics Product Portfolio Table 102. GlaxoSmithKline Recent Development Table 103. Baxter Company Information Table 104. Baxter Business Overview Table 105. Baxter Antiemetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Baxter Antiemetics Product Portfolio Table 107. Baxter Recent Development Table 108. Sanofi Aventis Company Information Table 109. Sanofi Aventis Business Overview Table 110. Sanofi Aventis Antiemetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Sanofi Aventis Antiemetics Product Portfolio Table 112. Sanofi Aventis Recent Development Table 113. Bristol Myers Squibb Company Information Table 114. Bristol Myers Squibb Business Overview Table 115. Bristol Myers Squibb Antiemetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Bristol Myers Squibb Antiemetics Product Portfolio Table 117. Bristol Myers Squibb Recent Development Table 118. Astellas Company Information Table 119. Astellas Business Overview Table 120. Astellas Antiemetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Astellas Antiemetics Product Portfolio Table 122. Astellas Recent Development Table 123. North America Antiemetics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. North America Antiemetics Sales by Country (2021-2026) & (K Units) Table 125. North America Antiemetics Sales Market Share by Country (2021-2026) Table 126. North America Antiemetics Sales Forecast by Country (2027-2032) & (K Units) Table 127. North America Antiemetics Sales Market Share Forecast by Country (2027-2032) Table 128. North America Antiemetics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Antiemetics Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Antiemetics Market Share by Country (2021-2026) Table 131. North America Antiemetics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Antiemetics Market Share Forecast by Country (2027-2032) Table 133. Europe Antiemetics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Europe Antiemetics Sales by Country (2021-2026) & (K Units) Table 135. Europe Antiemetics Sales Market Share by Country (2021-2026) Table 136. Europe Antiemetics Sales Forecast by Country (2027-2032) & (K Units) Table 137. Europe Antiemetics Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Antiemetics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Antiemetics Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Antiemetics Market Share by Country (2021-2026) Table 141. Europe Antiemetics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Antiemetics Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Antiemetics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Antiemetics Sales by Country (2021-2026) & (K Units) Table 145. Asia-Pacific Antiemetics Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Antiemetics Sales Forecast by Country (2027-2032) & (K Units) Table 147. Asia-Pacific Antiemetics Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Antiemetics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Antiemetics Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Antiemetics Market Share by Country (2021-2026) Table 151. Asia-Pacific Antiemetics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Antiemetics Market Share Forecast by Country (2027-2032) Table 153. Latin America Antiemetics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Latin America Antiemetics Sales by Country (2021-2026) & (K Units) Table 155. Latin America Antiemetics Sales Market Share by Country (2021-2026) Table 156. Latin America Antiemetics Sales Forecast by Country (2027-2032) & (K Units) Table 157. Latin America Antiemetics Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Antiemetics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Antiemetics Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Antiemetics Market Share by Country (2021-2026) Table 161. Latin America Antiemetics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Antiemetics Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Antiemetics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Antiemetics Sales by Country (2021-2026) & (K Units) Table 165. Middle East and Africa Antiemetics Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Antiemetics Sales Forecast by Country (2027-2032) & (K Units) Table 167. Middle East and Africa Antiemetics Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Antiemetics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Antiemetics Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Antiemetics Market Share by Country (2021-2026) Table 171. Middle East and Africa Antiemetics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Antiemetics Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Antiemetics Distributors List Table 176. Antiemetics Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Antiemetics Image Figure 2. Global Antiemetics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antiemetics Market Size (2021-2032) & (US$ Million) Figure 4. Global Antiemetics Sales (2021-2032) & (K Units) Figure 5. Steroids Image Figure 6. Global Steroids Sales YoY Growth (2021-2032) & (K Units) Figure 7. Antihistamines (H1 histamine receptor antagonists) Image Figure 8. Global Antihistamines (H1 histamine receptor antagonists) Sales YoY Growth (2021-2032) & (K Units) Figure 9. Anticholinergics Image Figure 10. Global Anticholinergics Sales YoY Growth (2021-2032) & (K Units) Figure 11. Dopamine antagonists Image Figure 12. Global Dopamine antagonists Sales YoY Growth (2021-2032) & (K Units) Figure 13. Cannabinoids Image Figure 14. Global Cannabinoids Sales YoY Growth (2021-2032) & (K Units) Figure 15. Benzodiazepines Image Figure 16. Global Benzodiazepines Sales YoY Growth (2021-2032) & (K Units) Figure 17. NK1 receptor antagonist Image Figure 18. Global NK1 receptor antagonist Sales YoY Growth (2021-2032) & (K Units) Figure 19. 5-HT3 receptor antagonists Image Figure 20. Global 5-HT3 receptor antagonists Sales YoY Growth (2021-2032) & (K Units) Figure 21. Others Image Figure 22. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 23. Global Antiemetics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 24. Global Antiemetics Market Share by Type 2025 VS 2032 Figure 25. North America Antiemetics Sales Market Share in Volume by Type in 2025 Figure 26. North America Antiemetics Sales Market Share in Value by Type in 2025 Figure 27. Europe Antiemetics Sales Market Share in Volume by Type in 2025 Figure 28. Europe Antiemetics Sales Market Share in Value by Type in 2025 Figure 29. Asia-Pacific Antiemetics Sales Market Share in Volume by Type in 2025 Figure 30. Asia-Pacific Antiemetics Sales Market Share in Value by Type in 2025 Figure 31. Latin America Antiemetics Sales Market Share in Volume by Type in 2025 Figure 32. Latin America Antiemetics Sales Market Share in Value by Type in 2025 Figure 33. Middle East and Africa Antiemetics Sales Market Share in Volume by Type in 2025 Figure 34. Middle East and Africa Antiemetics Sales Market Share in Value by Type in 2025 Figure 35. Global Top 5 and 10 Antiemetics Players Market Share by Revenue in 2025 Figure 36. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 37. Retail Pharmacy Image Figure 38. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 39. Online Pharmacy Image Figure 40. Global Online Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 41. Hospital Pharmacy Image Figure 42. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 43. Others Image Figure 44. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 45. Global Antiemetics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 46. Global Antiemetics Market Share by Application 2025 VS 2032 Figure 47. North America Antiemetics Sales Market Share in Volume by Application in 2025 Figure 48. North America Antiemetics Sales Market Share in Value by Application in 2025 Figure 49. Europe Antiemetics Sales Market Share in Volume by Application in 2025 Figure 50. Europe Antiemetics Sales Market Share in Value by Application in 2025 Figure 51. Asia-Pacific Antiemetics Sales Market Share in Volume by Application in 2025 Figure 52. Asia-Pacific Antiemetics Sales Market Share in Value by Application in 2025 Figure 53. Latin America Antiemetics Sales Market Share in Volume by Application in 2025 Figure 54. Latin America Antiemetics Sales Market Share in Value by Application in 2025 Figure 55. Middle East and Africa Antiemetics Sales Market Share in Volume by Application in 2025 Figure 56. Middle East and Africa Antiemetics Sales Market Share in Value by Application in 2025 Figure 57. North America Antiemetics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. North America Antiemetics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. North America Antiemetics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. North America Antiemetics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Antiemetics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Europe Antiemetics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Antiemetics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Europe Antiemetics Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Antiemetics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Asia-Pacific Antiemetics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Antiemetics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Asia-Pacific Antiemetics Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Antiemetics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 70. Latin America Antiemetics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Latin America Antiemetics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Latin America Antiemetics Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Antiemetics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 74. Middle East and Africa Antiemetics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 75. Middle East and Africa Antiemetics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 76. Middle East and Africa Antiemetics Market Share by Country: 2021 VS 2025 VS 2032 Figure 77. Antiemetics Value Chain Figure 78. Key Raw Materials Price Figure 79. Manufacturing Cost Structure Figure 80. Antiemetics Production Mode & Process Figure 81. Direct Comparison with Distribution Share Figure 82. Distributors Profiles Figure 83. Years Considered Figure 84. Research Process Figure 85. Key Executives Interviewed

Scope & coverage.

Types
  • Steroids
  • Antihistamines (H1 histamine receptor antagonists)
  • Anticholinergics
  • Dopamine antagonists
  • Cannabinoids
  • Benzodiazepines
  • NK1 receptor antagonist
  • 5-HT3 receptor antagonists
  • Others
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
  • Others
Companies covered
  • Johnson & Johnson
  • Merck
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Baxter
  • Sanofi Aventis
  • Bristol Myers Squibb
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antiemetics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antiemetics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antiemetics Market by Type
  6. 1.3.1 Steroids
  7. 1.3.2 Antihistamines (H1 histamine receptor antagonists)
  8. 1.3.3 Anticholinergics
  9. 1.3.4 Dopamine antagonists
  10. 1.3.5 Cannabinoids
  11. 1.3.6 Benzodiazepines
  12. 1.3.7 NK1 receptor antagonist
  13. 1.3.8 5-HT3 receptor antagonists
  14. 1.3.9 Others
  15. 1.4 Global Antiemetics Market Size by Type
  16. 1.4.1 Global Antiemetics Market Size Overview by Type (2021-2032)
  17. 1.4.2 Global Antiemetics Historic Market Size Review by Type (2021-2026)
  18. 1.4.3 Global Antiemetics Forecasted Market Size by Type (2027-2032)
  19. 1.5 Key Regions Market Size by Type
  20. 1.5.1 North America Antiemetics Sales Breakdown by Type (2021-2026)
  21. 1.5.2 Europe Antiemetics Sales Breakdown by Type (2021-2026)
  22. 1.5.3 Asia-Pacific Antiemetics Sales Breakdown by Type (2021-2026)
  23. 1.5.4 South America Antiemetics Sales Breakdown by Type (2021-2026)
  24. 1.5.5 Middle East and Africa Antiemetics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antiemetics Industry Trends
  2. 2.2 Antiemetics Industry Drivers
  3. 2.3 Antiemetics Industry Opportunities and Challenges
  4. 2.4 Antiemetics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antiemetics Revenue (2021-2026)
  2. 3.2 Global Top Players by Antiemetics Sales (2021-2026)
  3. 3.3 Global Top Players by Antiemetics Price (2021-2026)
  4. 3.4 Global Antiemetics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antiemetics Major Company Production Sites & Headquarters
  6. 3.6 Global Antiemetics Company, Product Type & Application
  7. 3.7 Global Antiemetics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antiemetics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antiemetics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antiemetics Tier 1, Tier 2, and Tier 3
4 Antiemetics Regional Status and Outlook
  1. 4.1 Global Antiemetics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antiemetics Historic Market Size by Region
  3. 4.2.1 Global Antiemetics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antiemetics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antiemetics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antiemetics Forecasted Market Size by Region
  7. 4.3.1 Global Antiemetics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antiemetics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antiemetics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antiemetics by Application
  1. 5.1 Antiemetics Market by Application
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Antiemetics Market Size by Application
  7. 5.2.1 Global Antiemetics Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Antiemetics Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Antiemetics Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Antiemetics Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Antiemetics Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Antiemetics Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Antiemetics Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Antiemetics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Antiemetics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Antiemetics Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Antiemetics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Antiemetics Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Antiemetics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly Antiemetics Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Antiemetics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Antiemetics Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Antiemetics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Antiemetics Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Baxter
  32. 6.6.1 Baxter Company Information
  33. 6.6.2 Baxter Business Overview
  34. 6.6.3 Baxter Antiemetics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Baxter Antiemetics Product Portfolio
  36. 6.6.5 Baxter Recent Developments
  37. 6.7 Sanofi Aventis
  38. 6.7.1 Sanofi Aventis Company Information
  39. 6.7.2 Sanofi Aventis Business Overview
  40. 6.7.3 Sanofi Aventis Antiemetics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sanofi Aventis Antiemetics Product Portfolio
  42. 6.7.5 Sanofi Aventis Recent Developments
  43. 6.8 Bristol Myers Squibb
  44. 6.8.1 Bristol Myers Squibb Company Information
  45. 6.8.2 Bristol Myers Squibb Business Overview
  46. 6.8.3 Bristol Myers Squibb Antiemetics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bristol Myers Squibb Antiemetics Product Portfolio
  48. 6.8.5 Bristol Myers Squibb Recent Developments
  49. 6.9 Astellas
  50. 6.9.1 Astellas Company Information
  51. 6.9.2 Astellas Business Overview
  52. 6.9.3 Astellas Antiemetics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Astellas Antiemetics Product Portfolio
  54. 6.9.5 Astellas Recent Developments
7 North America by Country
  1. 7.1 North America Antiemetics Sales by Country
  2. 7.1.1 North America Antiemetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antiemetics Sales by Country (2021-2026)
  4. 7.1.3 North America Antiemetics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antiemetics Market Size by Country
  6. 7.2.1 North America Antiemetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antiemetics Market Size by Country (2021-2026)
  8. 7.2.3 North America Antiemetics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antiemetics Sales by Country
  2. 8.1.1 Europe Antiemetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antiemetics Sales by Country (2021-2026)
  4. 8.1.3 Europe Antiemetics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antiemetics Market Size by Country
  6. 8.2.1 Europe Antiemetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antiemetics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antiemetics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antiemetics Sales by Country
  2. 9.1.1 Asia-Pacific Antiemetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antiemetics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antiemetics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antiemetics Market Size by Country
  6. 9.2.1 Asia-Pacific Antiemetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antiemetics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antiemetics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antiemetics Sales by Country
  2. 10.1.1 South America Antiemetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antiemetics Sales by Country (2021-2026)
  4. 10.1.3 South America Antiemetics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antiemetics Market Size by Country
  6. 10.2.1 South America Antiemetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antiemetics Market Size by Country (2021-2026)
  8. 10.2.3 South America Antiemetics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antiemetics Sales by Country
  2. 11.1.1 Middle East and Africa Antiemetics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antiemetics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antiemetics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antiemetics Market Size by Country
  6. 11.2.1 Middle East and Africa Antiemetics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antiemetics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antiemetics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antiemetics Value Chain Analysis
  2. 12.1.1 Antiemetics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antiemetics Production Mode & Process
  7. 12.2 Antiemetics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antiemetics Distributors
  10. 12.2.3 Antiemetics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.